Study of S-1 Plus LV for Untreated Metastatic Colorectal Cancer

NCT00891332 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

73

Enrollment

INDUSTRY

Sponsor class

Conditions

Colorectal Cancer

Interventions

DRUG: S-1 plus LV (The combination therapy of S-1 and Leucovorin)

Sponsor

Taiho Pharmaceutical Co., Ltd.